Predictions
Trillium Therapeutics
Start price
Target price
Perf. (%)
€8.76
22.08.20
22.08.20
-
07.09.20
07.09.20
-5.48%
07.09.20
07.09.20
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€4.27
14.07.20
14.07.20
€5.85
05.08.20
05.08.20
-5.09%
05.08.20
05.08.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aphria Inc.
Start price
Target price
Perf. (%)
€3.70
24.05.20
24.05.20
€5.00
26.06.20
26.06.20
-0.54%
26.06.20
26.06.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€1.01
28.04.20
28.04.20
€1.00
04.11.21
04.11.21
35.05%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
THC Biomed International Inc.
Start price
Target price
Perf. (%)
€0.070
17.04.20
17.04.20
-
04.11.21
04.11.21
-21.43%
14.10.21
14.10.21
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€13.53
30.03.20
30.03.20
€29.00
04.11.21
04.11.21
72.28%
05.11.21
05.11.21
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€7.15
26.03.20
26.03.20
-
04.11.21
04.11.21
10.29%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.44
13.03.20
13.03.20
€9.32
24.07.20
24.07.20
-15.48%
24.07.20
24.07.20
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€2.80
04.01.20
04.01.20
-
04.11.21
04.11.21
112.50%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€18.00
21.12.19
21.12.19
€30.00
04.11.21
04.11.21
-36.06%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Aphria Inc.
Start price
Target price
Perf. (%)
€4.29
25.11.19
25.11.19
-
04.11.21
04.11.21
196.12%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.73
03.06.19
03.06.19
€2.35
20.06.19
20.06.19
36.98%
20.06.19
20.06.19
Could be worthwhile Investment >10% per year
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€38.96
01.06.19
01.06.19
€49.79
25.06.19
25.06.19
28.90%
25.06.19
25.06.19
Could be worthwhile Investment >10% per year
Novelion Therapeutics Inc.
Start price
Target price
Perf. (%)
?0.83
27.05.19
27.05.19
€1.17
15.11.19
15.11.19
0.00%
15.11.19
15.11.19
Aptose Biosciences
Start price
Target price
Perf. (%)
€1.81
26.05.19
26.05.19
€2.71
05.07.19
05.07.19
49.91%
05.07.19
05.07.19
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€26.94
25.05.19
25.05.19
€40.00
27.07.20
27.07.20
-82.97%
27.07.20
27.07.20
Aphria Inc.
Start price
Target price
Perf. (%)
€7.73
16.04.19
16.04.19
€10.00
17.04.19
17.04.19
-6.47%
17.04.19
17.04.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€22.73
03.04.19
03.04.19
€27.06
12.03.20
12.03.20
-32.91%
12.03.20
12.03.20
Aphria Inc.
Start price
Target price
Perf. (%)
€8.65
15.02.19
15.02.19
€10.00
13.03.19
13.03.19
-2.31%
13.03.19
13.03.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.85
08.02.19
08.02.19
€21.00
04.11.21
04.11.21
372.71%
05.11.21
05.11.21
AEterna Zentaris Inc.
Start price
Target price
Perf. (%)
€89.30
03.02.19
03.02.19
€112.75
05.08.19
05.08.19
-42.42%
05.08.19
05.08.19
Canopy Growth Corp
Start price
Target price
Perf. (%)
€42.32
29.01.19
29.01.19
€23.00
12.05.20
12.05.20
-66.80%
12.05.20
12.05.20
Aphria Inc.
Start price
Target price
Perf. (%)
€6.14
24.01.19
24.01.19
€10.00
05.02.19
05.02.19
63.36%
05.02.19
05.02.19
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected